AVITA Medical Inc AVH
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AVH is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- A$2.66
- Day Range
- A$2.95–3.17
- 52-Week Range
- A$2.38–6.27
- Bid/Ask
- A$2.99 / A$3.00
- Market Cap
- A$385.71 Mil
- Volume/Avg
- 1.8 Mil / 370,839
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 4.39
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult patients in the US with paediatric clinical trials and expanded indications in soft-tissue reconstruction and vitiligo underway. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 207
- Website
- https://www.avitamedical.com
Competitors
Valuation
|
Metric
|
AVH
|
FPH
|
RMD
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 82.27 | 28.47 |
Price/Book Value | 6.67 | 9.79 | 6.49 |
Price/Sales | 4.39 | 9.84 | 6.65 |
Price/Cash Flow | — | 40.29 | 23.91 |
Price/Earnings
AVH
FPH
RMD
Financial Strength
|
Metric
|
AVH
|
FPH
|
RMD
|
|---|---|---|---|
Quick Ratio | 6.54 | 1.06 | 1.32 |
Current Ratio | 7.25 | 2.54 | 3.04 |
Interest Coverage | −17.57 | 25.77 | 22.63 |
Quick Ratio
AVH
FPH
RMD
Profitability
|
Metric
|
AVH
|
FPH
|
RMD
|
|---|---|---|---|
Return on Assets (Normalized) | −48.66% | 11.59% | 15.75% |
Return on Equity (Normalized) | −77.11% | 15.03% | 24.94% |
Return on Invested Capital (Normalized) | −58.44% | 14.12% | 19.33% |
Return on Assets
AVH
FPH
RMD
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Cwkgkgty | Hzlhwf | $177.8 Bil | |
SYK
| Stryker Corp | Wmxjvxwdh | Cwg | $127.8 Bil | |
BSX
| Boston Scientific Corp | Xbjplpgz | Wlzrrl | $110.3 Bil | |
MDT
| Medtronic PLC | Vdlfgzdhv | Hnrlrz | $105.7 Bil | |
EW
| Edwards Lifesciences Corp | Rlbmtjfy | Pxsvfss | $52.4 Bil | |
DXCM
| DexCom Inc | Yyyjqtnt | Vrqh | $50.5 Bil | |
PHG
| Koninklijke Philips NV ADR | Nxwzrfxkr | Qnmxnf | $25.6 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Cyjjpsjjl | Ypnx | $23.7 Bil | |
STE
| Steris PLC | Gljrczl | Frsdh | $22.0 Bil | |
ALGN
| Align Technology Inc | Zlztbcgw | Tntlghn | $19.4 Bil |